Assure Neuromonitoring

Assure Neuromonitoring is a best-in-class provider of outsourced intraoperative neuromonitoring (IONM) and remote neurology services. The company delivers a comprehensive suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that put the nervous system at risk, including neurosurgery, spine, cardiovascular, orthopedic, and ear, nose and throat surgeries. Assure employs highly trained technologists who serve as direct points of contact in the operating room, while physicians employed through its subsidiaries simultaneously monitor patients' neural structures' functional integrity throughout the procedure, communicating in real-time with the surgeon and technologist.

Assure's IONM services involve safeguarding patients' quality of life after highly complex surgeries. As the only publicly traded IONM company listed on the Nasdaq, Assure prides itself on being an industry leader in transparency, principled operations, and a commitment to ethical business standards. The company is accredited by The Joint Commission, reflecting its mission to provide exceptional surgical care and a positive patient experience.

In March 2024, Assure entered an agreement to sell certain assets of its IONM business, including most healthcare facility contracts, clinical equipment, and a majority of employees, to MPOWERHealth for up to USD 4.5 million. This strategic move aimed to repurpose Assure's business and facilitate its pending merger with Danam Health.